Evidence map›Paper›PMID 34578495›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters.

Ryan D Mellor, Andreas G Schätzlein, Ijeoma F Uchegbu

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Kinetically Arrested SERS-Active Aggregates for Biosensing.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  2. Review
  3. Clustered, SERS-Active, Ultrasmall AuNPs for Photothermal Therapy.International journal of nanomedicine · 2025
    Article
  4. Article
  5. Ultrasmall-in-Nano: Why Size Matters.Nanomaterials (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryan D MellorSchool of Pharmacy, University College London (UCL), 29-39 Brunswick Square, London WC1N 1AX, UK.ORCID 0000-0002-0677-5603
Andreas G SchätzleinSchool of Pharmacy, University College London (UCL), 29-39 Brunswick Square, London WC1N 1AX, UK.ORCID 0000-0003-3907-6603
Ijeoma F UchegbuSchool of Pharmacy, University College London (UCL), 29-39 Brunswick Square, London WC1N 1AX, UK.ORCID 0000-0001-9586-6867

Funding

Engineering and Physical Sciences Research Council EP/R020965/1
6 · The paper itself

Abstract

Gold nanoparticles (AuNPs) are used experimentally for non-invasive in vivo Raman monitoring because they show a strong absorbance in the phototherapeutic window (650-850 nm), a feature that is accompanied by a particle size in excess of 100 nm. However, these AuNPs cannot be used clinically because they are likely to persist in mammalian systems and resist excretion. In this work, clustered ultrasmall (sub-5 nm) AuNP constructs for in vivo Raman diagnostic monitoring, which are also suitable for mammalian excretion, were synthesized and characterized. Sub-5 nm octadecyl amine (ODA)-coated AuNPs were clustered using a labile dithiol linker: ethylene glycol bis-mercaptoacetate (EGBMA). Upon clustering via a controlled reaction and finally coating with a polymeric amphiphile, a strong absorbance in the phototherapeutic window was demonstrated, thus showing the potential suitability of the construct for non-invasive in vivo detection and monitoring. The clusters, when labelled with a biphenyl-4-thiol (BPT) Raman tag, were shown to elicit a specific Raman response in plasma and to disaggregate back to sub-5 nm particles under physiological conditions (37 °C, 0.8 mM glutathione, pH 7.4). These data demonstrate the potential of these new AuNP clusters (Raman NanoTheranostics-RaNT) for in vivo applications while being in the excretable size window.

Indexed as

excretablegoldRamantheranosticultrasmall-in-nano

Identifiers

PMID34578495
PMCPMC8471107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.